inflamed.communityinflamed.community

Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Sanchez · 2022 · Nutrients

What this paper found

Meta-analysis across 13 RCTs. CRP reduced significantly (mean difference −3.04 mg/L, p<0.001) but DAS28 disease activity score showed no consistent change after excluding high-risk-of-bias trials. Biochemical signal without clinical translation; strain-dependent, L. casei and L. acidophilus show the strongest individual signals.

Why this is on the map

Foundational evidence, predates the 2024–2026 platform window but remains the best available meta-analysis on probiotics in spondyloarthritis. Read with that age caveat.

On the map under this thread

Read the paper at the source →

DOI: 10.3390/nu14020354· opens in a new tab. The full paper is on the publisher’s site, not here.

Related papers on the board

Papers sharing one or more threads with this one.

Huang · 2026
Study

HLA-B27-associated gut microbiota and amino acid perturbations promote ankylosing spondylitis through M1 macrophage activation

Gut Microbes

Shows that HLA-B27, the gene most strongly linked to AS, reshapes which bacteria live in the gut and how the body handles certain amino acids, which in turn activates the inflammatory immune cells driving the disease. Suggests targeting the gut and these metabolic changes could become a real treatment route.

Gut–Immune AxisMacrophage M1 PolarisationHLA-B27 Genetics
Lobiuc · 2025
Review

Gut microbiota and ankylosing spondylitis: current insights and future challenges

Microbial Cell

Comprehensive review of how gut bacterial imbalance disrupts the IL-23/IL-17 inflammatory pathway and weakens the intestinal barrier in AS. Identifies the lack of standardised methodology and large cohorts as the bottleneck for translating this into treatments.

Gut–Immune AxisIL-23 / IL-17 Axis
, · 2025
Study

Dysbiosis of Gut Microbiota in Ankylosing Spondylitis Patients

Dove Medical Press

Confirms that intestinal dysfunction precedes or amplifies systemic inflammation in AS. Frames gut microbiota as the convergence point where genetic, immune, and microbial factors meet.

Gut–Immune AxisIL-23 / IL-17 Axis
Adawi · 2025
Review

The role of gut microbiota in autoimmune disease progression and therapy: a comprehensive synthesis

Frontiers in Microbiomes

Review and meta-analysis of dysbiosis across rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. Identifies bidirectional gut-immune interactions via mucosal modulation and T-regulatory cell activity.

Gut–Immune AxisIL-23 / IL-17 Axis
Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials · inflamed.community